The publisher has been monitoring the orthobiologics market and it is poised to grow by $2.02 billion during 2021-2025, progressing at a CAGR of 7.01% during the forecast period.
The report on the orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of orthopedic disorders coupled with an aging population and increase in focus to reduce orthopedic surgeries.
The orthobiologics market analysis includes the product segment and geographic landscape. This study identifies the rise in approvals and clearances for orthobiologics products as one of the prime reasons driving the orthobiologics market growth during the next few years.
Companies Mentioned
Advanced Medical Solutions Group Plc
Akcome Medical Holdings Co. Ltd.
Anika Therapeutics Inc.
Arthrex Inc.
Bioventus LLC
Globus Medical Inc.
Johnson and Johnson Inc.
Medtronic Plc
Nuvasive Inc.
Stryker Corp.
The report on orthobiologics market covers the following areas:
Orthobiologics market sizing
Orthobiologics market forecast
Orthobiologics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Key Topics Covered:
1. Executive Summary
Market overview
2. Market Landscape
Market ecosystem
Market characteristics
Value chain analysis
3. Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
4. Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
5. Market Segmentation by Product
Market segments
Comparison by Product
Bone graft substitutes - Market size and forecast 2020-2025
Viscosupplementation - Market size and forecast 2020-2025
Stem cells - Market size and forecast 2020-2025
Market opportunity by Product
6. Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Illinois House Speaker Emanuel "Chris" Welch was unanimously recommended to serve as the new Proviso Township Committeeman in a meeting held Friday evening of the Executive Committee, replacing the late Karen Yarbrough....
Nium, the global leader in real-time, cross-border payments, and Asia's leading payments, banking, and capital markets research firm, Kapronasia, today launched "Breaking Borders: The Revolution of Real-Time Cross-Border B2B Payments in Asia" - a new...
In a digital era where the app market continues to expand, driven by increased smartphone adoption and technological advancements, Appsketiers emerges as a beacon of hope for aspiring entrepreneurs and innovators. With a mission to democratize app...
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis.
The company's dividend is...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...